Core Laboratories Inc. /DE/CLB财报
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
CLB Q4 2025 Key Financial Metrics
营收
$138.3M
毛利润
$28.7M
营业利润
$15.8M
净利润
$4.9M
毛利率
20.8%
营业利润率
11.5%
净利率
3.6%
同比增长
7.0%
EPS
$0.11
资金流向
Core Laboratories Inc. /DE/ Q4 2025 财务摘要
Core Laboratories Inc. /DE/ reported revenue of $138.3M (up 7.0% YoY) for Q4 2025, with a net profit of $4.9M (down 33.2% YoY) (3.6% margin). Cost of goods sold was $109.5M, operating expenses totaled $12.9M.
核心财务指标
| 总营收 | $138.3M |
|---|---|
| 净利润 | $4.9M |
| 毛利率 | 20.8% |
| 营业利润率 | 11.5% |
| 报告期 | Q4 2025 |
营收拆解
Core Laboratories Inc. /DE/ Q4 2025 revenue of $138.3M breaks down across 2 segments, led by Services at $107.0M (77.4% of total).
| 业务分部 | 营收 | 占比 |
|---|---|---|
| Services | $107.0M | 77.4% |
| Products | $31.3M | 22.6% |
Core Laboratories Inc. /DE/ 分部营收 — 季度趋势
Core Laboratories Inc. /DE/ revenue by segment across the last 4 reported quarters, showing how each business line (such as Services and Products) has evolved quarter over quarter.
| 业务分部 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Services | $107.0M | $101.1M | $96.2M | $95.1M |
| Products | $31.3M | $33.4M | $33.9M | $28.5M |
Core Laboratories Inc. /DE/ 年度营收
Core Laboratories Inc. /DE/ annual revenue history includes year-by-year totals (for example, 2025 revenue was $526.5M). Click any linked year to see what changed vs the prior 10-K.
Core Laboratories Inc. /DE/ 季度营收与净利润历史
Core Laboratories Inc. /DE/ quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 季度 | 营收 | 营收同比 | 净利润 | 净利率 |
|---|---|---|---|---|
| Q4 2025 | $138.3M | +7.0% | $4.9M | 3.6% |
| Q3 2025 | $134.5M | +0.1% | $14.2M | 10.6% |
| Q2 2025 | $130.2M | -0.3% | $10.6M | 8.2% |
| Q1 2025 | $123.6M | -4.7% | $-154.0K | -0.1% |
| Q4 2024 | $129.2M | — | $7.4M | 5.7% |
| Q3 2024 | $134.4M | +7.2% | $11.7M | 8.7% |
| Q2 2024 | $130.6M | +2.1% | $9.0M | 6.9% |
| Q1 2024 | $129.6M | — | $3.2M | 2.5% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $129.6M | $130.6M | $134.4M | $129.2M | $123.6M | $130.2M | $134.5M | $138.3M |
| 同比增长 | N/A | 2.1% | 7.2% | N/A | -4.7% | -0.3% | 0.1% | 7.0% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $597.8M | $597.8M | $600.5M | $585.1M | $591.5M | $602.1M | $591.4M | $584.0M |
| 总负债 | $365.6M | $357.5M | $349.7M | $338.6M | $338.1M | $340.8M | $320.0M | $318.0M |
| 股东权益 | $232.2M | $240.3M | $250.7M | $246.6M | $253.4M | $261.3M | $271.3M | $266.0M |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $5.5M | $17.1M | $13.1M | $20.6M | $6.7M | $13.9M | $8.5M | $7.9M |